UICC GLOBALink Presents...
The Tobacco Reference Guide
by David Moyer, MD.


Chapter 22 Smoking and tobacco cessation

tobacco reference guideg (artefact pour

Smoking and tobacco cessation: Nicotine replacement and

pharmacologic treatment

globalink (artefact pour saut de ligne)

The FDA in 1997 approved the antidepressant bupropion (marketed by Glaxo as

Zyban) as the first nicotine-free antismoking drug. It appears to reduce the desire for

tobacco.

Associated Press, May 16, 1997

tobacco reference guideg (artefact pour saut

In a study from the Mayo Clinic on smoking cessation, the antidepressant bupropion

at 150 milligrams twice a day for seven weeks, beginning one week before the quit

date, was found to be similar in clinical efficacy to nicotine replacement therapy. At the

above dose, the rate of smoking cessation was 44% at six weeks and 23% at one

year on bupropion (Zyban), compared to 23% and 12.4%, respectively, in the placebo

group. The drug was well tolerated, with the most common side effects being

headache, dry mouth, and difficulty sleeping. The average weight gain was only 1.5

kilograms, compared with the typical weight gain associated with successful smoking

cessation of 3 to 4 kg.

NEJM, October 23, 1997, pp. 1195-1202

tobacco reference guideg (artefact pour saut

Zyban sales were $151 million in the United States in 1998, and were expected to

increase to $250 million in 1999.

New York Times, March 19, 1999, p. C1

tobacco reference guideg (artefact pour saut

In a new approach with 4000 smokers, 40% to 60% remained smoke-free a year after

completing a program combining nicotine replacement delivered through patches,

gum, nasal spray or inhalers, the antidepressant buproprion (Zyban), and individual

counseling. The 40 to 60% success rates compare with 10 to 20% success at one

year among smokers who try to quit by using nicotine replacement alone.

New York Times, March 2, 1999, p. D1

tobacco reference guideg (artefact pour saut

tobacco reference guideg (artefact pour

Thursday, July 06, 2000 Page 19 of 25

globalink (artefact pour saut de ligne)
First page of this chapter        Previous page of this chapter        Next page of this chapter
Last page of this chapter

Copyright (©) 2000 - David Moyer - published on UICC GLOBALink